{"doi":"10.1093/ajh/hpaf240","title":"Clinician Fidelity with Hypertension Quality Improvement Program is Associated with Blood Pressure Control within a Clinician-Patient Panel","abstract":"BACKGROUND: Differences in clinician fidelity with hypertension quality improvement (QI) interventions may influence blood pressure (BP) control. METHODS: This analysis included data from 35,115 patients with 89,230 clinical encounters during a calendar year conducted by 87 physicians, 7 advanced practice nurses, and 173 residents to examine the association of fidelity measures with QI interventions and BP control for a clinician-patient panel. BP control (BP < 140/90 mm Hg) was based on vital signs at last clinic visit. The QI program fidelity measures included (1) documented automated office BP (AOBP) to confirm initial elevated BP, (2) 30-day follow-up visits when clinic BP is uncontrolled, (3) appropriate escalation of medications during visits with uncontrolled BP, and (4) use of combination BP-lowering medications. Linear mixed-effects models were used to examine the association of QI program fidelity measure quartiles with patient panel BP control, while adjusting for patient panel characteristics. RESULTS: The mean patient age was 63.2 years (SD 12.8), 45.1% were men; race/ethnicity was Non-Hispanic (NH) White in 60.5%, NH Black in 20.3%, and Hispanic in 14.0%. Average patient panel BP control rate was 69.1%. After adjustment, the highest AOBP and 30-day follow-up visit quartiles were associated with a 15.1% (95% CI, 8.9%-21.4%) and 12.3% (95% CI, 6.8%-17.7%) higher percentage of clinician-patient panels with controlled BP compared to the lowest quartile. No association was noted with other fidelity measures and BP control. CONCLUSION: Increasing fidelity with hypertension QI interventions may help clinicians improve BP control rates within their patient panel.","journal":"American Journal of Hypertension","year":2025,"id":585203,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9538,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":367077,"name":"Talar Markossian","orcid":"0000-0002-8147-7083","position":1,"is_corresponding":false},{"id":1085316,"name":"Beatrice D. Probst","orcid":null,"position":2,"is_corresponding":false},{"id":1307797,"name":"Katherine Habicht","orcid":null,"position":3,"is_corresponding":false},{"id":24792,"name":"Holly Kramer","orcid":"0000-0002-6374-837X","position":4,"is_corresponding":false},{"id":1119932,"name":"Matthew Dimond","orcid":"0000-0002-3996-6721","position":0,"is_corresponding":true}],"reference_count":17,"raw_metadata":null,"created_at":"2026-07-19T02:59:20.067334Z","pmid":"41390954","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}